Alberto Bardelli
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 302 publications
Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
The Rising Burden of Early-Onset Cancer: Challenges and Opportunities.
Journal: Cancer discovery
Published: February 15, 2026
Mapping intratumor heterogeneity across layers for advancing immunotherapy.
Journal: Cell
Published: January 27, 2026
Pharmacologic Inhibition of PMS2 Induces MMR Deficiency and Response to Immune Checkpoint Blockade.
Journal: Cancer discovery
Published: January 04, 2026
A subset of MMR-proficient colon cancers responds to neoadjuvant immunotherapy.
Journal: Molecular oncology
Published: November 18, 2025
Degrees of H2AX phosphorylation correlate with unique features of the intratumoral immune microenvironment in colorectal carcinomas.
Journal: The oncologist
Published: November 05, 2025
WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.
Journal: EMBO molecular medicine
Published: September 30, 2025
Correction: Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer.
Journal: Clinical and experimental medicine
Published: July 29, 2025
Last Updated: 09/26/2026